Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME
CAPABILITIES
Why Single Cell
SNV
SNV + CNV
DNA + Protein
Applications
Oncology Research
Multiple Myeloma
AML MRD
Precision Medicine
Genome Editing
Genome Integrity Assay
Biomarker Development
Cell and Gene Therapy
Products & Services
Tapestri Platform
Panels
Pharma Assay Development
PAD for Cell & Gene Therapy
PAD for Drug Development
RESOURCES
BLOG
PODCAST
COMPANY
About Us
Careers
Newsroom
Events
Distributors & Service Providers
SUPPORT CENTER
CONTACT
PORTAL
X
COMPANY
SUPPORT CENTER
CONTACT
PORTAL
SEARCH
CAPABILITIES
APPLICATIONS
PRODUCTS & SERVICES
RESOURCES
MENU
Why Single Cell
Single-cell Genomics
SNV
SNV + CNV
Single-cell Multi-omics
DNA + Protein
Oncology Research
Hematologic Malignancies
Solid Tumors
Multiple Myeloma
AML MRD
Precision Medicine
Biomarker Development
Cell and Gene Therapy
Pharma Assay Development
Genome Editing
Genome Integrity Assay
Panels
Tapestri Platform
Pharma Assay Development
PAD for Cell & Gene Therapy
PAD for Drug Development
LIBRARY
All Resources
Scientific Presentations
Researcher Spotlights
Videos
Brochures
Datasets
User Guides
Technical Notes
Posters
Publications
LEARNING CENTER
BLOG
PODCAST
About Us
Careers
Newsroom
Events
Distributors & Service Providers
Home
Company
Newsroom
News & Media
Press Releases
News
View All
press
December 5, 2024
Mission Bio Showcases Critical Insights Into Multiple Myeloma, AML MRD, CAR-T Safety & Integrated Single-Cell DNA and Fusion Profiling at the 2024 ASH Annual Meeting
press
December 2, 2024
Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients
press
September 26, 2024
Mission Bio Launches Innovative Single-cell Genome Integrity Solution to Measure Whole Genome Copy Number Variation in Advanced Therapies and Tumor Samples
news
August 21, 2024
Detecting Translocations in Gene Edited Cells
news
August 21, 2024
Using Single Cell Sequencing for Gene Editing Quality Control
press
August 20, 2024
Mission Bio’s Tapestri Platform Utilized in Development of Advancements in Gene-Edited T-Cell Therapy
LOAD MORE
REQUEST QUOTE